Syncom Formulations (India) Ltd.
•₹ 16.144.4%
2026-08-21
ABOUT
KEY POINTS
Revenue Breakup Mar 2025 • Pharmacutical Drugs & Formulations: 97.5% • Trading of Comodities: 1.7% • Renting of Property: 0.8%
PROS
- Company has delivered good profit growth of 36.7% CAGR over last 5 years
- Company is almost debt free
- Latest quarter profit grew 57.7% YoY, showing strong momentum
- Company has consistently been profitable over the last 5 years
- Company has delivered good sales growth of 20.4% CAGR over last 5 years
CONS
- A large part of profit comes from other income (26.6% of PBT)
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.30x)
- Recurring exceptional / one-off items are inflating headline profit
- Though reporting repeated profits, the company pays out little dividend (0.0%)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | SYNCOMF | 15.35 | 16.87 | 1442.90 | 0.00 | 24.85 | 57.72 | 125.53 | 7.38 | 18.77 | 20.88 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60 | 64 | 65 | 75 | 87 | 102 | 128 | 149 | 117 | 122 | 115 | 135 | 126 | |
| 53 | 57 | 58 | 65 | 77 | 90 | 113 | 131 | 101 | 103 | 94 | 113 | 101 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 2 | 4 | 5 | 3 | 1 | 4 | 4 | 7 | 6 | 5 | 6 | 15 | 8 |
| Interest | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| 6 | 8 | 9 | 10 | 10 | 15 | 17 | 23 | 20 | 22 | 25 | 34 | 32 | |
| Tax % | 28.15% | 22.96% | 25.21% | 26.22% | 24.46% | 25.19% | 24.68% | 24.08% | 22.38% | 24.68% | 24.63% | 25.31% | 22.96% |
| Net Profit | 0 | 0 | 0 | 0 | 8 | 11 | 13 | 18 | 16 | 17 | 19 | 25 | 25 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Equity Capital | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 60
- 53
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 1
- Depreciation
- 1
- 6
- Tax %
- 28.15%
- Net Profit
- 0
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 64
- 57
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 1
- Depreciation
- 1
- 8
- Tax %
- 22.96%
- Net Profit
- 0
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 65
- 58
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 1
- Depreciation
- 1
- 9
- Tax %
- 25.21%
- Net Profit
- 0
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 75
- 65
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 1
- Depreciation
- 1
- 10
- Tax %
- 26.22%
- Net Profit
- 0
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 87
- 77
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 1
- 10
- Tax %
- 24.46%
- Net Profit
- 8
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 102
- 90
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 0
- Depreciation
- 1
- 15
- Tax %
- 25.19%
- Net Profit
- 11
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 128
- 113
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 0
- Depreciation
- 1
- 17
- Tax %
- 24.68%
- Net Profit
- 13
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 149
- 131
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- 0
- Depreciation
- 1
- 23
- Tax %
- 24.08%
- Net Profit
- 18
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 117
- 101
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 0
- Depreciation
- 1
- 20
- Tax %
- 22.38%
- Net Profit
- 16
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 122
- 103
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 0
- Depreciation
- 1
- 22
- Tax %
- 24.68%
- Net Profit
- 17
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 115
- 94
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 0
- Depreciation
- 1
- 25
- Tax %
- 24.63%
- Net Profit
- 19
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 135
- 113
- Operating Profit
- —
- OPM %
- —
- Other Income
- 15
- Interest
- 0
- Depreciation
- 2
- 34
- Tax %
- 25.31%
- Net Profit
- 25
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 126
- 101
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 0
- Depreciation
- 2
- 32
- Tax %
- 22.96%
- Net Profit
- 25
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| 115 | 151 | 173 | 184 | 185 | 220 | 224 | 263 | 465 | 498 | |
| 104 | 135 | 155 | 167 | 168 | 200 | 204 | 234 | 411 | 412 | |
| Operating Profit | 12 | 17 | 20 | 19 | 19 | 32 | 34 | 43 | 72 | — |
| OPM % | 10 | 11 | 12 | 11 | 10 | 15 | 15 | 16 | 15 | — |
| Other Income | 1 | 1 | 2 | 3 | 3 | 12 | 15 | 14 | 17 | 33 |
| Interest | 1 | 0 | 0 | 0 | 0 | 2 | 3 | 4 | 1 | 1 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 4 | 5 | 5 | 5 | 7 |
| 8 | 14 | 16 | 16 | 16 | 26 | 27 | 34 | 66 | 113 | |
| Tax % | 33 | 33 | 38 | 36 | 34 | 24 | 24 | 25 | 25 | 24 |
| Net Profit | 6 | 9 | 10 | 10 | 11 | 20 | 20 | 25 | 49 | 86 |
| EPS | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | — |
| Dividend Payout % | 24 | 17 | 16 | 15 | 15 | 13 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | — |
Mar 2013
- 115
- 104
- Operating Profit
- 12
- OPM %
- 10
- Other Income
- 1
- Interest
- 1
- Depreciation
- 3
- 8
- Tax %
- 33
- Net Profit
- 6
- EPS
- 3
- Dividend Payout %
- 24
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2014
- 151
- 135
- Operating Profit
- 17
- OPM %
- 11
- Other Income
- 1
- Interest
- 0
- Depreciation
- 3
- 14
- Tax %
- 33
- Net Profit
- 9
- EPS
- 0
- Dividend Payout %
- 17
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2015
- 173
- 155
- Operating Profit
- 20
- OPM %
- 12
- Other Income
- 2
- Interest
- 0
- Depreciation
- 3
- 16
- Tax %
- 38
- Net Profit
- 10
- EPS
- 0
- Dividend Payout %
- 16
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2016
- 184
- 167
- Operating Profit
- 19
- OPM %
- 11
- Other Income
- 3
- Interest
- 0
- Depreciation
- 3
- 16
- Tax %
- 36
- Net Profit
- 10
- EPS
- 0
- Dividend Payout %
- 15
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2017
- 185
- 168
- Operating Profit
- 19
- OPM %
- 10
- Other Income
- 3
- Interest
- 0
- Depreciation
- 3
- 16
- Tax %
- 34
- Net Profit
- 11
- EPS
- 0
- Dividend Payout %
- 15
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2022
- 220
- 200
- Operating Profit
- 32
- OPM %
- 15
- Other Income
- 12
- Interest
- 2
- Depreciation
- 4
- 26
- Tax %
- 24
- Net Profit
- 20
- EPS
- 0
- Dividend Payout %
- 13
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2023
- 224
- 204
- Operating Profit
- 34
- OPM %
- 15
- Other Income
- 15
- Interest
- 3
- Depreciation
- 5
- 27
- Tax %
- 24
- Net Profit
- 20
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2024
- 263
- 234
- Operating Profit
- 43
- OPM %
- 16
- Other Income
- 14
- Interest
- 4
- Depreciation
- 5
- 34
- Tax %
- 25
- Net Profit
- 25
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2025
- 465
- 411
- Operating Profit
- 72
- OPM %
- 15
- Other Income
- 17
- Interest
- 1
- Depreciation
- 5
- 66
- Tax %
- 25
- Net Profit
- 49
- EPS
- 1
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
TTM
- 498
- 412
- Operating Profit
- —
- OPM %
- —
- Other Income
- 33
- Interest
- 1
- Depreciation
- 7
- 113
- Tax %
- 24
- Net Profit
- 86
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 20%
- 3 Years:
- 28%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 37%
- 3 Years:
- 36%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 23%
- 1 Year:
- -11%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 11%
- 3 Years:
- 11%
- Last Year:
- 16%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - |
| Equity Capital | 22 | 78 | 78 | 78 | 78 | 86 | 94 | 94 | 94 |
| 65 | 17 | 22 | 31 | 39 | 131 | 162 | 194 | 248 | |
| 2 | 3 | 6 | 6 | 12 | 58 | 83 | 72 | 5 | |
| Trade Payables | 19 | 29 | 20 | 47 | 32 | 14 | 20 | 24 | 43 |
| 15 | 16 | 16 | 19 | 22 | 19 | 18 | 22 | 26 | |
| Total Liabilities | 124 | 144 | 143 | 181 | 184 | 308 | 378 | 407 | 416 |
| ASSETS | - | - | - | - | - | - | - | - | - |
| 50 | 50 | 46 | 46 | 55 | 47 | 43 | 72 | 78 | |
| Capital Work in Progress | 0 | 0 | 0 | 5 | 0 | 6 | 26 | 0 | 0 |
| 7 | 9 | 6 | 23 | 36 | 43 | 64 | 66 | 93 | |
| 6 | 10 | 11 | 15 | 10 | 20 | 21 | 21 | 41 | |
| 0 | 0 | 0 | 0 | 0 | 68 | 0 | 103 | 108 | |
| Cash & Bank | 4 | 5 | 7 | 6 | 7 | 0 | 9 | 68 | 1 |
| 57 | 69 | 73 | 86 | 76 | 125 | 215 | 76 | 96 | |
| Total Assets | 124 | 144 | 143 | 181 | 184 | 308 | 378 | 407 | 416 |
| Total Debt | 2 | 3 | 6 | 6 | 12 | 58 | 83 | 72 | 5 |
| Net Working Capital | 33 | 36 | 47 | 26 | 28 | 62 | 69 | 168 | 211 |
| Contingent Liabilities | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 |
| Book Value per Share | 39.32 | 1.22 | 1.28 | 1.39 | 1.50 | 2.52 | 2.72 | 3.07 | 3.64 |
| Face Value | 10.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Total Debt | 2 | 3 | 6 | 6 | 12 | 58 | 83 | 72 | 5 |
| Net Working Capital | 33 | 36 | 47 | 26 | 28 | 62 | 69 | 168 | 211 |
| Contingent Liabilities | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 |
| Book Value per Share | 39.32 | 1.22 | 1.28 | 1.39 | 1.50 | 2.52 | 2.72 | 3.07 | 3.64 |
| Face Value | 10.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Mar 2013
- Equity Capital
- 22
- 65
- 2
- Trade Payables
- 19
- 15
- Total Liabilities
- 124
- 50
- Capital Work in Progress
- 0
- 7
- 6
- 0
- Cash & Bank
- 4
- 57
- Total Assets
- 124
- Total Debt
- 2
- Net Working Capital
- 33
- Contingent Liabilities
- 2
- Book Value per Share
- 39.32
- Face Value
- 10.00
- Total Debt
- 2
- Net Working Capital
- 33
- Contingent Liabilities
- 2
- Book Value per Share
- 39.32
- Face Value
- 10.00
Mar 2014
- Equity Capital
- 78
- 17
- 3
- Trade Payables
- 29
- 16
- Total Liabilities
- 144
- 50
- Capital Work in Progress
- 0
- 9
- 10
- 0
- Cash & Bank
- 5
- 69
- Total Assets
- 144
- Total Debt
- 3
- Net Working Capital
- 36
- Contingent Liabilities
- 1
- Book Value per Share
- 1.22
- Face Value
- 1.00
- Total Debt
- 3
- Net Working Capital
- 36
- Contingent Liabilities
- 1
- Book Value per Share
- 1.22
- Face Value
- 1.00
Mar 2015
- Equity Capital
- 78
- 22
- 6
- Trade Payables
- 20
- 16
- Total Liabilities
- 143
- 46
- Capital Work in Progress
- 0
- 6
- 11
- 0
- Cash & Bank
- 7
- 73
- Total Assets
- 143
- Total Debt
- 6
- Net Working Capital
- 47
- Contingent Liabilities
- 1
- Book Value per Share
- 1.28
- Face Value
- 1.00
- Total Debt
- 6
- Net Working Capital
- 47
- Contingent Liabilities
- 1
- Book Value per Share
- 1.28
- Face Value
- 1.00
Mar 2016
- Equity Capital
- 78
- 31
- 6
- Trade Payables
- 47
- 19
- Total Liabilities
- 181
- 46
- Capital Work in Progress
- 5
- 23
- 15
- 0
- Cash & Bank
- 6
- 86
- Total Assets
- 181
- Total Debt
- 6
- Net Working Capital
- 26
- Contingent Liabilities
- 1
- Book Value per Share
- 1.39
- Face Value
- 1.00
- Total Debt
- 6
- Net Working Capital
- 26
- Contingent Liabilities
- 1
- Book Value per Share
- 1.39
- Face Value
- 1.00
Mar 2017
- Equity Capital
- 78
- 39
- 12
- Trade Payables
- 32
- 22
- Total Liabilities
- 184
- 55
- Capital Work in Progress
- 0
- 36
- 10
- 0
- Cash & Bank
- 7
- 76
- Total Assets
- 184
- Total Debt
- 12
- Net Working Capital
- 28
- Contingent Liabilities
- 3
- Book Value per Share
- 1.50
- Face Value
- 1.00
- Total Debt
- 12
- Net Working Capital
- 28
- Contingent Liabilities
- 3
- Book Value per Share
- 1.50
- Face Value
- 1.00
Mar 2022
- Equity Capital
- 86
- 131
- 58
- Trade Payables
- 14
- 19
- Total Liabilities
- 308
- 47
- Capital Work in Progress
- 6
- 43
- 20
- 68
- Cash & Bank
- 0
- 125
- Total Assets
- 308
- Total Debt
- 58
- Net Working Capital
- 62
- Contingent Liabilities
- 1
- Book Value per Share
- 2.52
- Face Value
- 1.00
- Total Debt
- 58
- Net Working Capital
- 62
- Contingent Liabilities
- 1
- Book Value per Share
- 2.52
- Face Value
- 1.00
Mar 2023
- Equity Capital
- 94
- 162
- 83
- Trade Payables
- 20
- 18
- Total Liabilities
- 378
- 43
- Capital Work in Progress
- 26
- 64
- 21
- 0
- Cash & Bank
- 9
- 215
- Total Assets
- 378
- Total Debt
- 83
- Net Working Capital
- 69
- Contingent Liabilities
- 1
- Book Value per Share
- 2.72
- Face Value
- 1.00
- Total Debt
- 83
- Net Working Capital
- 69
- Contingent Liabilities
- 1
- Book Value per Share
- 2.72
- Face Value
- 1.00
Mar 2024
- Equity Capital
- 94
- 194
- 72
- Trade Payables
- 24
- 22
- Total Liabilities
- 407
- 72
- Capital Work in Progress
- 0
- 66
- 21
- 103
- Cash & Bank
- 68
- 76
- Total Assets
- 407
- Total Debt
- 72
- Net Working Capital
- 168
- Contingent Liabilities
- 1
- Book Value per Share
- 3.07
- Face Value
- 1.00
- Total Debt
- 72
- Net Working Capital
- 168
- Contingent Liabilities
- 1
- Book Value per Share
- 3.07
- Face Value
- 1.00
Mar 2025
- Equity Capital
- 94
- 248
- 5
- Trade Payables
- 43
- 26
- Total Liabilities
- 416
- 78
- Capital Work in Progress
- 0
- 93
- 41
- 108
- Cash & Bank
- 1
- 96
- Total Assets
- 416
- Total Debt
- 5
- Net Working Capital
- 211
- Contingent Liabilities
- 1
- Book Value per Share
- 3.64
- Face Value
- 1.00
- Total Debt
- 5
- Net Working Capital
- 211
- Contingent Liabilities
- 1
- Book Value per Share
- 3.64
- Face Value
- 1.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| 6 | 7 | 0 | 24 | 14 | 16 | 11 | -6 | 23 | |
| Cash from Investing | -0 | -4 | 1 | -23 | -18 | -27 | -45 | 83 | -18 |
| Cash from Financing | -6 | -1 | 1 | -2 | 5 | 8 | 35 | -15 | -68 |
| -1 | 2 | 1 | -1 | 1 | -2 | 1 | 63 | -63 | |
| Free Cash Flow | 6 | 4 | -3 | 17 | 9 | 2 | -10 | -14 | 13 |
| OCF / Net Profit | 1.02 | 0.72 | 0.02 | 2.32 | 1.31 | 0.83 | 0.52 | -0.24 | 0.47 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | 29 | 15 | 4 | -0 |
| OCF / Net Profit | 1.02 | 0.72 | 0.02 | 2.32 | 1.31 | 0.83 | 0.52 | -0.24 | 0.47 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | 29 | 15 | 4 | -0 |
Mar 2013
- 6
- Cash from Investing
- -0
- Cash from Financing
- -6
- -1
- Free Cash Flow
- 6
- OCF / Net Profit
- 1.02
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.02
- Cumulative 5-Year FCF
- 0
Mar 2014
- 7
- Cash from Investing
- -4
- Cash from Financing
- -1
- 2
- Free Cash Flow
- 4
- OCF / Net Profit
- 0.72
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.72
- Cumulative 5-Year FCF
- 0
Mar 2015
- 0
- Cash from Investing
- 1
- Cash from Financing
- 1
- 1
- Free Cash Flow
- -3
- OCF / Net Profit
- 0.02
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.02
- Cumulative 5-Year FCF
- 0
Mar 2016
- 24
- Cash from Investing
- -23
- Cash from Financing
- -2
- -1
- Free Cash Flow
- 17
- OCF / Net Profit
- 2.32
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.32
- Cumulative 5-Year FCF
- 0
Mar 2017
- 14
- Cash from Investing
- -18
- Cash from Financing
- 5
- 1
- Free Cash Flow
- 9
- OCF / Net Profit
- 1.31
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.31
- Cumulative 5-Year FCF
- 0
Mar 2022
- 16
- Cash from Investing
- -27
- Cash from Financing
- 8
- -2
- Free Cash Flow
- 2
- OCF / Net Profit
- 0.83
- Cumulative 5-Year FCF
- 29
- OCF / Net Profit
- 0.83
- Cumulative 5-Year FCF
- 29
Mar 2023
- 11
- Cash from Investing
- -45
- Cash from Financing
- 35
- 1
- Free Cash Flow
- -10
- OCF / Net Profit
- 0.52
- Cumulative 5-Year FCF
- 15
- OCF / Net Profit
- 0.52
- Cumulative 5-Year FCF
- 15
Mar 2024
- -6
- Cash from Investing
- 83
- Cash from Financing
- -15
- 63
- Free Cash Flow
- -14
- OCF / Net Profit
- -0.24
- Cumulative 5-Year FCF
- 4
- OCF / Net Profit
- -0.24
- Cumulative 5-Year FCF
- 4
Mar 2025
- 23
- Cash from Investing
- -18
- Cash from Financing
- -68
- -63
- Free Cash Flow
- 13
- OCF / Net Profit
- 0.47
- Cumulative 5-Year FCF
- -0
- OCF / Net Profit
- 0.47
- Cumulative 5-Year FCF
- -0
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 2.54 | 0.12 | 0.12 | 0.13 | 0.13 | 0.23 | 0.21 | 0.27 | 0.53 |
| Book Value (₹) | 39.32 | 1.22 | 1.28 | 1.39 | 1.50 | 2.52 | 2.72 | 3.07 | 3.64 |
| Dividend per Share (₹) | 0.60 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 0.11 | 0.16 | 0.17 | 0.17 | 0.17 | 0.28 | 0.26 | 0.32 | 0.58 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 10.26% | 11.47% | 11.63% | 10.42% | 10.47% | 9.12% | 15.38% | 11.26% | 11.64% |
| Net Margin % | 4.92% | 6.14% | 5.62% | 5.58% | 5.70% | 9.01% | 8.95% | 9.61% | 10.63% |
| ROE % | 6.45% | 10.19% | 9.99% | 9.91% | 9.32% | 11.83% | 8.48% | 9.30% | 15.69% |
| ROCE % | 10.00% | 15.29% | 15.55% | 14.72% | 13.28% | 13.72% | 9.68% | 10.98% | 18.77% |
| 4.54% | 6.95% | 6.82% | 6.41% | 5.78% | 8.04% | 5.85% | 6.45% | 12.02% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - |
| Debtor Days | 92 | 70 | 64 | 76 | 91 | 94 | 116 | 124 | 83 |
| Inventory Days | 19 | 19 | 22 | 26 | 25 | 25 | 33 | 29 | 24 |
| Payable Days | 119 | 118 | 107 | 115 | 141 | 80 | 62 | 69 | 46 |
| -8 | -28 | -21 | -13 | -25 | 39 | 87 | 84 | 62 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.02x | 0.03x | 0.06x | 0.05x | 0.11x | 0.27x | 0.32x | 0.25x | 0.01x |
| Interest Coverage (x) | 17.10x | 30.75x | 54.58x | 119.10x | 48.48x | 14.58x | 8.81x | 8.59x | 76.75x |
| 2.18x | 1.88x | 2.28x | 1.40x | 1.47x | 1.79x | 1.61x | 2.55x | 4.41x | |
| GROWTH | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 0.00% | 31.61% | 14.61% | 6.06% | 0.50% | 18.85% | 2.09% | 17.45% | 76.55% |
| Operating Profit Growth % | 0.00% | 47.35% | 16.09% | -4.21% | 0.03% | 65.57% | 7.72% | 25.14% | 65.76% |
| Net Profit Growth % | 0.00% | 64.72% | 4.72% | 6.14% | 1.72% | 87.87% | 1.42% | 26.13% | 95.28% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 70.10% | 0.00% | 26.14% | 95.28% | |
| VALUATION | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 46.32x | 0.00x | 41.52x | 31.28x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 4.22x | 0.00x | 3.65x | 4.52x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.28% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 30.42x | 0.00x | 24.45x | 21.66x |
Mar 2013
- EPS (₹)
- 2.54
- Book Value (₹)
- 39.32
- Dividend per Share (₹)
- 0.60
- Cash EPS (₹)
- 0.11
- Operating Margin %
- 10.26%
- Net Margin %
- 4.92%
- ROE %
- 6.45%
- ROCE %
- 10.00%
- 4.54%
- Debtor Days
- 92
- Inventory Days
- 19
- Payable Days
- 119
- -8
- Debt to Equity (x)
- 0.02x
- Interest Coverage (x)
- 17.10x
- 2.18x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2014
- EPS (₹)
- 0.12
- Book Value (₹)
- 1.22
- Dividend per Share (₹)
- 0.02
- Cash EPS (₹)
- 0.16
- Operating Margin %
- 11.47%
- Net Margin %
- 6.14%
- ROE %
- 10.19%
- ROCE %
- 15.29%
- 6.95%
- Debtor Days
- 70
- Inventory Days
- 19
- Payable Days
- 118
- -28
- Debt to Equity (x)
- 0.03x
- Interest Coverage (x)
- 30.75x
- 1.88x
- Revenue Growth %
- 31.61%
- Operating Profit Growth %
- 47.35%
- Net Profit Growth %
- 64.72%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2015
- EPS (₹)
- 0.12
- Book Value (₹)
- 1.28
- Dividend per Share (₹)
- 0.02
- Cash EPS (₹)
- 0.17
- Operating Margin %
- 11.63%
- Net Margin %
- 5.62%
- ROE %
- 9.99%
- ROCE %
- 15.55%
- 6.82%
- Debtor Days
- 64
- Inventory Days
- 22
- Payable Days
- 107
- -21
- Debt to Equity (x)
- 0.06x
- Interest Coverage (x)
- 54.58x
- 2.28x
- Revenue Growth %
- 14.61%
- Operating Profit Growth %
- 16.09%
- Net Profit Growth %
- 4.72%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2016
- EPS (₹)
- 0.13
- Book Value (₹)
- 1.39
- Dividend per Share (₹)
- 0.02
- Cash EPS (₹)
- 0.17
- Operating Margin %
- 10.42%
- Net Margin %
- 5.58%
- ROE %
- 9.91%
- ROCE %
- 14.72%
- 6.41%
- Debtor Days
- 76
- Inventory Days
- 26
- Payable Days
- 115
- -13
- Debt to Equity (x)
- 0.05x
- Interest Coverage (x)
- 119.10x
- 1.40x
- Revenue Growth %
- 6.06%
- Operating Profit Growth %
- -4.21%
- Net Profit Growth %
- 6.14%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2017
- EPS (₹)
- 0.13
- Book Value (₹)
- 1.50
- Dividend per Share (₹)
- 0.02
- Cash EPS (₹)
- 0.17
- Operating Margin %
- 10.47%
- Net Margin %
- 5.70%
- ROE %
- 9.32%
- ROCE %
- 13.28%
- 5.78%
- Debtor Days
- 91
- Inventory Days
- 25
- Payable Days
- 141
- -25
- Debt to Equity (x)
- 0.11x
- Interest Coverage (x)
- 48.48x
- 1.47x
- Revenue Growth %
- 0.50%
- Operating Profit Growth %
- 0.03%
- Net Profit Growth %
- 1.72%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 0.23
- Book Value (₹)
- 2.52
- Dividend per Share (₹)
- 0.03
- Cash EPS (₹)
- 0.28
- Operating Margin %
- 9.12%
- Net Margin %
- 9.01%
- ROE %
- 11.83%
- ROCE %
- 13.72%
- 8.04%
- Debtor Days
- 94
- Inventory Days
- 25
- Payable Days
- 80
- 39
- Debt to Equity (x)
- 0.27x
- Interest Coverage (x)
- 14.58x
- 1.79x
- Revenue Growth %
- 18.85%
- Operating Profit Growth %
- 65.57%
- Net Profit Growth %
- 87.87%
- 70.10%
- P/E (x)
- 46.32x
- P/B (x)
- 4.22x
- Dividend Yield %
- 0.28%
- 30.42x
Mar 2023
- EPS (₹)
- 0.21
- Book Value (₹)
- 2.72
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.26
- Operating Margin %
- 15.38%
- Net Margin %
- 8.95%
- ROE %
- 8.48%
- ROCE %
- 9.68%
- 5.85%
- Debtor Days
- 116
- Inventory Days
- 33
- Payable Days
- 62
- 87
- Debt to Equity (x)
- 0.32x
- Interest Coverage (x)
- 8.81x
- 1.61x
- Revenue Growth %
- 2.09%
- Operating Profit Growth %
- 7.72%
- Net Profit Growth %
- 1.42%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 0.27
- Book Value (₹)
- 3.07
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.32
- Operating Margin %
- 11.26%
- Net Margin %
- 9.61%
- ROE %
- 9.30%
- ROCE %
- 10.98%
- 6.45%
- Debtor Days
- 124
- Inventory Days
- 29
- Payable Days
- 69
- 84
- Debt to Equity (x)
- 0.25x
- Interest Coverage (x)
- 8.59x
- 2.55x
- Revenue Growth %
- 17.45%
- Operating Profit Growth %
- 25.14%
- Net Profit Growth %
- 26.13%
- 26.14%
- P/E (x)
- 41.52x
- P/B (x)
- 3.65x
- Dividend Yield %
- 0.00%
- 24.45x
Mar 2025
- EPS (₹)
- 0.53
- Book Value (₹)
- 3.64
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.58
- Operating Margin %
- 11.64%
- Net Margin %
- 10.63%
- ROE %
- 15.69%
- ROCE %
- 18.77%
- 12.02%
- Debtor Days
- 83
- Inventory Days
- 24
- Payable Days
- 46
- 62
- Debt to Equity (x)
- 0.01x
- Interest Coverage (x)
- 76.75x
- 4.41x
- Revenue Growth %
- 76.55%
- Operating Profit Growth %
- 65.76%
- Net Profit Growth %
- 95.28%
- 95.28%
- P/E (x)
- 31.28x
- P/B (x)
- 4.52x
- Dividend Yield %
- 0.00%
- 21.66x
Documents
Announcements
- General Updates
2026-08-13 - Syncom Formulations (India) Limited has informed the Exchange about General Updates
- Disclosure of material issue
2026-08-13 - Syncom Formulations (India) Limited has informed regarding Disclosure of material issue
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nothing filed yet.